Steven C. Plaxe

UC San Diego Health System — United States

Medicine · Health Sciences

29h-index4.0kcitations192works0.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Endometrial and Cervical Cancer Treatments(58), Ovarian cancer diagnosis and treatment(57), Cervical Cancer and HPV Research(21), Uterine Myomas and Treatments(17), Intraperitoneal and Appendiceal Malignancies(16)

Publications192 total

Abdominal wall blocks in robotic hysterectomy for endometrial cancer are associated with a modest reduction in the frequency of patients receiving post-operative intravenous opioids
Gynecologic Oncology Reports·2025Open Access
Discovery and structural identification of human endogenous retrovirus-K env monoclonal antibody: Uncovering viral epitopes in ovarian cancer
Gynecologic Oncology·2025
Prior to FDA approval of pembrolizumab, the use of immunotherapy for primary treatment of advanced cervical cancer was frequent and unequally distributed: A National Cancer Database study (2014–2021)
Gynecologic Oncology·2025
Narcotic Waste Associated with Postoperative Patient-Controlled Analgesia in Gynecologic Oncology Surgery: A Retrospective Review
Current Women s Health Reviews·2025
Abstract #40: Palliative care referral and utilization at time of diagnosis in patients with recurrent or advanced stage gynecologic cancers at a single institution
Gynecologic Oncology Reports·2024Open Access
Abstract #7: Consideration of PARPi therapy in patients with uterine leiomyosarcoma harboring homologous recombination deficiency repair mutations
Gynecologic Oncology Reports·2024Open Access
Temozolomide overcoming resistance to immune checkpoint inhibitors in relapsed/refractory metastatic melanoma? Insights from a single center series
Journal of Oncology Pharmacy Practice·2024· 3 cited
Tumor risk factors are not consistently used to make postoperative radiation recommendations: A multivariate analysis
Gynecologic Oncology·2024
RAS/RAF/MEK mutated high-grade serous ovarian cancer susceptible to Raf inhibition in vitro but not in vivo
Gynecologic Oncology·2024
Focal adhesion kinase inhibitors as maintenance therapy in a homologous recombination repair proficient high-grade serous ovarian cancer murine model
Gynecologic Oncology·2024
Sjogren's syndrome due to immune checkpoint inhibitors (ICIs): Insights from a single-institution series and systematic review of the literature
Journal of Oncology Pharmacy Practice·2024· 1 cited
38 Use of postoperative opioids in patients undergoing robotic hysterectomy for endometrial cancer with or without abdominal wall block
Gynecologic Oncology Reports·2023Open Access
37 HPV vaccination rates among women 27–45 rose more slowly after ACOG's statement recommending shared decision making
Gynecologic Oncology Reports·2023Open Access
40 Comparison of contemporary management and outcomes of patients with transitional cell carcinomas and malignant Brenner tumors of the ovary
Gynecologic Oncology Reports·2023Open Access
22 Patients with stage 1 endometrial cancer frequently do not receive guideline recommended postoperative radiation
Gynecologic Oncology Reports·2023· 1 citedOpen Access
P20 Superficial myometrial invasion and chemotherapy are associated with improved outcomes in patients with stage 1 uterine carcinosarcoma
Gynecologic Oncology·2023
Acquired angioedema late in the course of nivolumab treatment
Journal of Oncology Pharmacy Practice·2023
Data from Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
2023Open Access
Supplementary Data from Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
2023Open Access
Data from Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Michael McHale(15), Cheryl Saenz(14), Kristy Ward(11), Edward F. McClay(7), Ramez N. Eskander(6), Nina R. Shah(5), Stephen B. Howell(5), Patricia S. Braly(4), Carmel J. Cohen(4), James L. Freddo(4), S Kirmani(4), Pratibha Binder(4), Angelica M. Roncancio(3), Lindsey M. Charo(3), John Einck(3), Loren K. Mell(3), Catheryn M. Yashar(3), Dennis D. Heath(3), John A. Blessing(3), David Cella(2)